Kuros Biosciences AG (0RHR.L)
CHF 20.55
(1.23%)
CHF 20.55
(1.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 33.56 Million | 17.98 Million | 13.81 Million | 4.03 Million | 2.56 Million | 715 Thousand |
| Cost of Revenue | 10.69 Million | 7.21 Million | 3.74 Million | 2.36 Million | 2.64 Million | 3.41 Million |
| Gross Profit | 22.87 Million | 10.76 Million | 10.06 Million | 1.67 Million | -79 Thousand | -2.7 Million |
| Operating Expenses | 36.21 Million | 24.21 Million | 18.83 Million | 13.35 Million | 11.31 Million | 11.02 Million |
| Selling, General and Administrative Expenses | 31.09 Million | 11.15 Million | 7.38 Million | 4.69 Million | 1.54 Million | 2.77 Million |
| Research and Development Expenses | 5.59 Million | 5.19 Million | 4.98 Million | 4 Million | 6.47 Million | 6.88 Million |
| Other Expenses | - | 7.86 Million | 6.46 Million | 4.65 Million | 9.77 Million | 8.25 Million |
| Cost and Expenses | 46.91 Million | 31.43 Million | 22.58 Million | 15.71 Million | 13.95 Million | 14.44 Million |
| Operating Income | -13.19 Million | -13.44 Million | -8.76 Million | -11.67 Million | -11.39 Million | -13.72 Million |
| Interest Expense | 186 Thousand | 4.31 Million | 1.38 Million | 848 Thousand | 651 Thousand | 126 Thousand |
| Income Tax Expense | 380 Thousand | -1.39 Million | -2.01 Million | -574 Thousand | -571 Thousand | -2.12 Million |
| Earnings before Tax | -13.34 Million | -15.99 Million | -9.55 Million | -12.09 Million | -11.82 Million | -13.81 Million |
| Net Income | -13.72 Million | -14.59 Million | -7.54 Million | -11.52 Million | -11.25 Million | -11.69 Million |
| Earnings Per Share Basic | -0.38 | -0.43 | -0.23 | -0.47 | -0.66 | -1.14 |
| Earnings Per Share Diluted | -0.38 | -0.43 | -0.23 | -0.47 | -0.66 | -1.14 |
| Weighted Average Shares Outstanding | 36.58 Million | 33.9 Million | 32.79 Million | 24.31 Million | 17.17 Million | 10.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.58 Million | 33.9 Million | 32.79 Million | 24.31 Million | 17.17 Million | 10.24 Million |
| Gross Margin | 0.68 | 0.60 | 0.73 | 0.41 | -0.03 | -3.78 |
| EBIT Margin | -0.31 | -0.49 | -0.38 | -2.12 | -3.30 | -16.42 |
| Profit Margin | -0.41 | -0.81 | -0.55 | -2.85 | -4.39 | -16.35 |
| EBITDA | -10.4 Million | -8.84 Million | -5.29 Million | -8.57 Million | -8.45 Million | -11.74 Million |
| Earnings Before Tax Margin | -0.39 | -0.75 | -0.63 | -2.89 | -4.45 | -19.20 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 31.84 Million | 20.69 Million | 33.56 Million | 10.34 Million | 12.86 Million | 6.43 Million |
| Cost of Revenue | 3.92 Million | 3.27 Million | 5.78 Million | 3.12 Million | 2.5 Million | 2.21 Million |
| Gross Profit | 27.91 Million | 17.42 Million | 27.78 Million | 7.21 Million | 10.36 Million | 4.21 Million |
| Operating Expenses | 28.58 Million | 21.67 Million | 36.68 Million | 11.45 Million | 15.01 Million | 6.65 Million |
| Selling, General and Administrative Expenses | 25.02 Million | 18.36 Million | - | 9.34 Million | 12.72 Million | 6.54 Million |
| Research and Development Expenses | 3.56 Million | 3.3 Million | - | 2.66 Million | 2.29 Million | 1.14 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 32.51 Million | 24.94 Million | 42.46 Million | 14.58 Million | 17.52 Million | 8.87 Million |
| Operating Income | -673 Thousand | -4.24 Million | -8.9 Million | -2.06 Million | -4.65 Million | -2.26 Million |
| Interest Expense | 434 Thousand | 2.89 Million | 186 Thousand | - | 1.04 Million | - |
| Income Tax Expense | 1.3 Million | 208 Thousand | 380 Thousand | 104 Thousand | 172 Thousand | 86 Thousand |
| Earnings before Tax | 1.09 Million | -8.46 Million | -13.34 Million | -4.23 Million | -4.88 Million | -2.44 Million |
| Net Income | -211 Thousand | -8.67 Million | -13.72 Million | -4.33 Million | -5.05 Million | -2.52 Million |
| Earnings Per Share Basic | -0.01 | -0.24 | - | -0.12 | -0.14 | -0.07 |
| Earnings Per Share Diluted | -0.01 | -0.24 | - | -0.12 | -0.14 | -0.07 |
| Weighted Average Shares Outstanding | 37.1 Million | 36.6 Million | 36.58 Million | 36.34 Million | 36.54 Million | 36.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.1 Million | 36.6 Million | 36.58 Million | 37.07 Million | 36.54 Million | 36.08 Million |
| Gross Margin | 0.88 | 0.84 | 0.83 | 0.70 | 0.81 | 0.66 |
| EBIT Margin | 0.02 | -0.14 | - | -0.15 | -0.25 | -0.27 |
| Profit Margin | -0.01 | -0.42 | -0.41 | -0.42 | -0.39 | -0.39 |
| EBITDA | 605 Thousand | -2.9 Million | - | -1.54 Million | -3.24 Million | -1.73 Million |
| Earnings Before Tax Margin | -0.02 | -0.21 | -0.27 | -0.20 | -0.36 | -0.35 |
NNSCF
NEGXF
MCSHF
NBR
6843
FFSB